DutyPills.com

DPP-4 inhibitor

Sitagliptin half-life and pharmacokinetics

Half-life describes how long it takes plasma concentration of Sitagliptin to drop by half after a dose. It is the most useful single number for understanding why Sitagliptin (Sitagliptin) is dosed the way it is — once daily, on demand, or some other schedule. The 25mg, 50mg, 100mg strengths and tablet formulation tune the curve.

Why half-life matters

Sitagliptin reaches peak plasma levels some hours after dosing, then decays. Short half-life agents are out of the system quickly and well-suited to event-driven dosing. Long half-life agents allow once-daily continuous coverage but accumulate over the first few days until reaching steady state. Sitagliptin reversibly inhibits DPP-4, the serine protease responsible for rapid degradation of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

Practical dose-pacing

According to the prescribing information for Sitagliptin, the dosing interval reflects the half-life and the desired duration of effect. Re-dosing inside the half-life window stacks plasma concentration without proportional benefit; spacing doses correctly keeps the steady-state where it is expected. The 25mg, 50mg, 100mg options exist to allow personalised exposure within this framework.

Frequently asked questions

How long does Sitagliptin stay in your system?

Most active drug clears within four to five half-lives. For Sitagliptin the exact half-life is in the prescribing information, but residual measurable drug may persist longer than the subjective effect at 25mg, 50mg, 100mg.

Can Sitagliptin accumulate over time?

Daily dosing of any drug accumulates until plasma concentrations reach steady state, typically within four to five half-lives. After that, Sitagliptin stays at predictable levels as long as the 25mg, 50mg, 100mg dose is unchanged. This is by design and is not the same as harmful accumulation.

Products containing Sitagliptin

More on Sitagliptin

The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.